{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Exton",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95190",
      "recalling_firm": "ProRx LLC",
      "address_1": "619 Jeffers Cir",
      "address_2": "",
      "postal_code": "19341-2540",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0650-2024",
      "product_description": "Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial,  ProRx, 267-565-7008, NDC 84139-225-01",
      "product_quantity": "2,490 vials",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20240822",
      "center_classification_date": "20240905",
      "report_date": "20240911",
      "code_info": "Lot #: ProRx031924, BUD 09/18/2024 ProRx032624, BUD 09/25/2024 ProRx041324, BUD 10/12/2024",
      "more_code_info": ""
    }
  ]
}